KOHALA COAST, Hawaii, Jan. 28, 2014 /PRNewswire/ -- AQUAGOLD® fine touch(TM) was presented at the 2014 Winter Clinical Dermatology Conference in Hawaii during a session on "New Procedures for the Aging Face". Dr. Mark Nestor, Director of the Center for Cosmetic Enhancement® and Director of the Center for Clinical and Cosmetic Research in Aventura, Florida, introduced AQUAGOLD® fine touch(TM), a unique microneedle device that effectively and comfortably delivers small droplets of treatment solutions directly into the skin allowing for greater absorption of the active ingredients. AQUAGOLD® fine touch(TM) treatments can address fine lines, increase collagen stimulation and improve overall moisture and rejuvenation of the skin. Dr. Nestor also outlined how the AQUAGOLD® fine touch(TM) device can be used to compliment other common procedures such as Botox Cosmetic®, Juvederm®, Restylane® and many other aesthetic treatments.
The Winter Clinical Dermatology Conference is designed to provide the practicing dermatologist with a comprehensive updates on the diagnosis and treatment of a variety of conditions related to medical, surgical and appearance dermatology.
"We will be launching AQUAGOLD® fine touch(TM) at the American Academy of Dermatology in Denver in March. We are extremely pleased by the early interest of key opinion leaders such as Dr. Nestor," said Sobin Chang, CEO of Aquavit Pharmaceuticals.
AQUAGOLD® fine touch(TM) is first-of-its-kind, FDA registered direct dermal application device. Aquavit Pharmaceuticals acquired an exclusive, perpetual global license to commercialize AQUAGOLD® fine touch(TM) and derivative technologies in mid-2013. Dr. Mark Nestor is also a Voluntary Associate Professor of the Department of Dermatology and Cutaneous Surgery at the University Of Miami Leonard Miller School Of Medicine and co-chairman of the Board of Directors of Advanced Dermatology Management. Dr. Nestor is a past President of the American Society for Photodynamic Therapy, the International Society for Cosmetic and Laser Surgeons, and Florida Society of Dermatology and Dermatologic Surgery.
About Aquavit Pharmaceuticals, Inc.
Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, medical devices and health technologies. For more information, visit www.aquavitpharma.com or www.aquagoldfinetouch.com.
SOURCE Aquavit Pharmaceuticals, Inc.